Home › Funds › SurgoCap Partners LP › TSM
SurgoCap Partners LP position in TSM
TAIWAN SEMICONDUCTOR MANUFAC · Technology
SurgoCap Partners LP reported holding 1,085,185 shares of TSM (TAIWAN SEMICONDUCTOR MANUFAC) in its Q3 2026 13F filing — a position valued at US$495.1M, representing 16.27% of its reported portfolio and ranking #1 among its reported holdings. SurgoCap Partners LP has disclosed TSM holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How SurgoCap Partners LP's TSM position evolved
SurgoCap Partners LP first disclosed a stake in TSM in Q3 2025 at 1,290,570 shares (US$360.4M). The position peaked in Q3 2026 at 1,085,185 shares, worth US$495.1M. Across 5 filings, SurgoCap Partners LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,085,185 shares valued at US$495.1M — an increase of 177,121 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.29M | $360.44M | New |
| Q4 2025 | 1.11M | $337.19M | Reduce |
| Q1 2026 | 1.11M | $374.47M | Hold |
| Q2 2026 | 908.06K | $433.66M | Reduce |
| Q3 2026 | 1.09M | $495.05M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TSM and 13F data
TSM (TAIWAN SEMICONDUCTOR MANUFAC) is a Technology company. 42 other funds we track also report a position in TSM — the largest reported positions include Fidelity Management & Research (FMR) (US$29.82B), Capital World Investors (US$16.41B), Capital World Investors (US$15.42B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TSM
- Fidelity Management & Research (FMR) 65.37M sh · $29.82B · Q3 2026
- Capital World Investors 34.37M sh · $16.41B · Q2 2026
- Capital World Investors 33.80M sh · $15.42B · Q3 2026
- Sanders Capital, LLC 24.46M sh · $11.16B · Q3 2026
- Fisher Asset Management, LLC 18.93M sh · $8.64B · Q3 2026
- VAN ECK ASSOCIATES CORP 17.21M sh · $7.85B · Q3 2026
- Bank of America Corp 16.74M sh · $7.63B · Q3 2026
- Morgan Stanley 16.19M sh · $7.39B · Q3 2026
- Goldman Sachs Group 15.22M sh · $7.27B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 11.32M sh · $5.41B · Q2 2026
- Capital Research Global Investors 10.47M sh · $5.00B · Q2 2026
- Capital International Investors 10.94M sh · $4.99B · Q3 2026
More on SurgoCap Partners LP
FAQ
How long has SurgoCap Partners LP held TSM?
SurgoCap Partners LP has disclosed TSM holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is SurgoCap Partners LP's current position in TSM?
As of Q3 2026, SurgoCap Partners LP holds 1.09M shares of TSM (TAIWAN SEMICONDUCTOR MANUFAC), valued at $495.05M, representing 16.27% of its reported portfolio and ranking #1.
Has SurgoCap Partners LP been buying or selling TSM?
In the latest 13F filing (Q3 2026), SurgoCap Partners LP increased its position in TSM. The position peaked in Q3 2026 at 1.09M shares.
Which other funds hold TSM?
Other major institutional holders of TSM include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.